A novel direct adenosine monophosphate kinase activator ameliorates disease progression in preclinical models of Autosomal Dominant Polycystic Kidney Disease-Reference-Cited by-同舟云学术

A novel direct adenosine monophosphate kinase activator ameliorates disease progression in preclinical models of Autosomal Dominant Polycystic Kidney Disease

Published:2023-05 Issue:5 Volume:103 Page:917-929
ISSN:0085-2538
Container-title:Kidney International
language:en
Short-container-title:Kidney International

Author:

Dagorn Pascale Gluais^ORCID,Buchholz Bjoern^ORCID,Kraus Andre,Batchuluun Battsetseg,Bange Hester,Blockken Laura,Steinberg Gregory R.,Moller David E.,Hallakou-Bozec Sophie^ORCID

Funder

Deutsche Forschungsgemeinschaft

Publisher

Elsevier BV

Subject

Nephrology

Reference62 articles.

1. Polycystic kidney disease;Bergmann;Nat Rev Dis Primers,2018

2. AMPK and polycystic kidney disease drug development: an interesting off-target target;Caplan;Front Med (Lausanne),2022

3. Analysis of nationwide data to determine the incidence and diagnosed prevalence of autosomal dominant polycystic kidney disease in the USA: 2013-2015;Willey;Kidney Dis (Basel),2019

4. Autosomal dominant polycystic kidney disease;Torres;Lancet,2007

5. Polycystic kidney disease;Harris;Annu Rev Med,2009

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The AMPK activator ATX-304 alters cellular metabolism to protect against cisplatin-induced acute kidney injury;Biomedicine & Pharmacotherapy;2024-06

2. Computational drug discovery approaches identify mebendazole as a candidate treatment for autosomal dominant polycystic kidney disease;Frontiers in Pharmacology;2024-05-23

3. AMPK as a mediator of tissue preservation: time for a shift in dogma?;Nature Reviews Endocrinology;2024-05-17

4. Mitochondrial dysfunction: mechanisms and advances in therapy;Signal Transduction and Targeted Therapy;2024-05-15

5. Novel Potential Therapeutic Targets in Autosomal Dominant Polycystic Kidney Disease from the Perspective of Cell Polarity and Fibrosis;Biomolecules & Therapeutics;2024-04-09